NASDAQ$LIVN

LivaNova PLC · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

LivaNova PLC Q1 fiscal 2026: $362.3M revenue, $22.3M net income

for the quarter ended March 31, 2026, the following terms and abbreviations have the meanings listed below. (SEC accession 0001639691-26-000035)

  • Revenue: $362.3M
  • Net income: $22.3M
  • Diluted EPS: $0.40
  • Operating income: $41.5M
  • Gross profit: $243.7M

Headline financials

Total Revenue

$362M

Previous: $317M+14.3%
EPS (adj)

$0.40

Previous: $0.88-54.5%
Capital Expenditures

-$14.3M

Previous: -$10.8M-32.4%
Net Income

$22.3M

Previous: -$327M+106.8%
Operating Income

$41.5M

Previous: $48.6M-14.7%
Gross Profit

$244M

Previous: $221M+10.4%

Revenue & EPS history

LivaNova · Revenue · Quarterly

$362M

Q1 2026+14.3%vs Q1 2025
Beat estimate in 14 of 15 quarters(93%)
ActualEstimate

Revenue by segment

LivaNova · $265M total across 3 segments · Q4 2022

  • Cardiopulmonary
    $137M
  • Neuromodulation
    $127M
  • Other Revenue
    $1.6M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+1.2%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+0.7%

Avg return

30 days after

58%

26 / 45 earnings

Positive

+23.3%

Q1 2025

Best reaction

-19.9%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+15.1%+21.7%
Q4 2025+0.8%+1.8%-10.4%
Q3 2025-5.8%-5.7%+17.5%
Q1 2025+23.3%+28.6%+30.7%
Q4 2024-15.8%-15.9%-20.0%
Q3 2024-2.5%-7.5%-0.9%
Q2 2024-5.8%-11.8%-1.8%
Q1 2024+12.9%+12.3%+9.5%
Q4 2023+6.9%+6.4%+6.4%
Q3 2023-0.8%-0.9%-6.4%
Q2 2023+7.0%+9.1%+4.0%
Q1 2023+0.6%-0.0%-0.6%
Q4 2022-9.6%-12.1%-23.6%
Q3 2022+2.2%+6.6%+19.1%
Q2 2022-3.0%-2.2%-13.9%
Q1 2022-13.2%-21.8%-9.1%
Q4 2021+7.9%+9.4%+8.6%
Q3 2021+15.3%+15.9%+2.4%
Q2 2021+8.0%+7.1%+1.1%
Q1 2021+3.8%+1.4%+0.8%
Q4 2020+3.5%+3.6%+2.6%
Q3 2020+1.0%-4.5%+8.9%
Q2 2020-11.0%-17.2%-14.9%
Q1 2020-5.8%-10.4%-5.1%
Q4 2019+3.3%+5.2%-34.6%
Q3 2019-6.8%-6.4%+10.4%
Q2 2019+5.8%+1.7%+2.5%
Q1 2019+5.2%+8.8%+4.4%
Q4 2018-4.2%-3.1%+0.0%
Q3 2018+5.6%+6.9%-6.6%
Q2 2018+12.2%+10.3%+14.0%
Q1 2018-8.0%-6.7%+5.9%
Q4 2017+2.4%+0.8%+1.1%
Q3 2017+11.7%+9.1%+20.3%
Q2 2017+1.4%+1.5%+7.7%
Q1 2017+4.0%+4.8%+7.0%
Q4 2016+4.2%-2.0%-2.8%
Q3 2016-19.9%-21.0%-19.3%
Q2 2016+14.9%+11.1%+12.0%
Q1 2016-3.5%
Q4 2014-0.0%
Q4 2013-0.0%
Q4 2015-1.1%
Q2 2015+1.9%
Q3 2015-10.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro